Natera Stock News

Natera Inc (NTRA) shares closed 0.3% lower than its previous 52 week low, giving the company a market cap of $8B. The stock is currently down 5.7% year-to-date, down 8.6% over the past 12 months, and up 639.8% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 42.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -608.0% The company's stock price performance over the past 12 months lags the peer average by -123.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

AUSTIN, Texas, Jan. 4, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in personalized genetic testing and diagnostics, today announced that it will webcast a live presentation at the 40t

Look for surprise values in underpriced stocks. Not the story issues being bally-hooed by touts and the media – everyone knows them. The hidden values are ones found by experienced professional rese

Understanding the State of the Genomics Market

Related Stocks: BMBL , CNC , CFLT , MSCI , SNOW , AMG , PANW , NTRA , HOLX , RELY , ITRI , XLNX , BAH , AMED , PINS , CI , RNG , LVS , COUP , SWK ,

Equities analysts expect that Natera, Inc. (NASDAQ:NTRA) will announce sales of $168.88 million for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for Nateras earnings. The lowest sales estimate is $167.60 million and the highest is $169.37 million. Natera reported sales of $112.40 million in the same quarter last year, which indicates []

Natera, Inc. (NASDAQ:NTRA) CFO Michael Burkes Brophy sold 1,196 shares of the businesss stock in a transaction on Friday, December 10th. The stock was sold at an average price of $91.33, for a total transaction of $109,230.68. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. []

Related Stocks: MRNA , BIIB , VRTX , ICLR , TECH , NTRA , NTLA , ALXN , NBIX , QDEL , IONS ,

Natera, Inc. (NASDAQ:NTRA) insider Daniel Rabinowitz sold 899 shares of Natera stock in a transaction on Friday, December 10th. The shares were sold at an average price of $91.33, for a total value of $82,105.67. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this […]

Natera, Inc. (NASDAQ:NTRA) CEO Steven Leonard Chapman sold 4,726 shares of the businesss stock in a transaction that occurred on Tuesday, December 7th. The stock was sold at an average price of $91.99, for a total value of $434,744.74. The sale was disclosed in a document filed with the SEC, which is available through this []

Related Stocks: NTRA ,

Natera, Inc. (NASDAQ:NTRA) CEO Steven Leonard Chapman sold 7,219 shares of the businesss stock in a transaction on Wednesday, December 1st. The stock was sold at an average price of $90.80, for a total transaction of $655,485.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at []

Thrivent Financial for Lutherans lessened its stake in Natera, Inc. (NASDAQ:NTRA) by 15.8% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 236,233 shares of the medical research companys stock after selling 44,349 shares during the quarter. Thrivent Financial for Lutherans owned 0.25% of Natera worth $26,820,000 as []